← Browse by Condition
Medical Condition

erectile dysfunction

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1

ClinicalMetric tracks all active clinical trials for erectile dysfunction sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — erectile dysfunction Clinical Trials

How many clinical trials are currently recruiting for erectile dysfunction?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for erectile dysfunction, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for erectile dysfunction?
erectile dysfunction research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a erectile dysfunction clinical trial?
Eligibility criteria for erectile dysfunction trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Cairo University 1 trial
University of California, Irvine 1 trial
Regina Elena Cancer Institute 1 trial
Stanford University 1 trial
The Foundation for Orthopaedics and Regenerative Medicine 1 trial

Recruiting Clinical Trials

NCT06783894
Recruiting

Elliptical Physical Activity and Sexual Dysfunction in Males With Irritable Bowel Syndrome

Enrollment
40 pts
Location
Egypt
Sponsor
Cairo University
View Trial →
NCT06720597
Recruiting

EndoPAT Device for Endothelial Dysfunction in ED

Enrollment
120 pts
Location
United States
Sponsor
University of California, Irvi...
View Trial →
NCT06442020
Recruiting

Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy.

Enrollment
158 pts
Location
Italy
Sponsor
Regina Elena Cancer Institute
View Trial →
NCT05451563
Recruiting

Double-S: a Wearable Device for Erectile Dysfunction

Enrollment
10 pts
Location
United States
Sponsor
Stanford University
View Trial →
NCT05147779 Phase 1
Recruiting

Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells for Peyronie's Disease, ED, and Interstitial Cystitis

Enrollment
20 pts
Location
Antigua and Barbuda
Sponsor
The Foundation for Orthopaedic...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology